BiOptic Inc. (TPEX:6850)
Taiwan · Delayed Price · Currency is TWD 36.15
-0.10 (-0.28%)
At close: Apr 24, 2026
BiOptic Market Cap
BiOptic has a market cap or net worth of 1.2 billion as of April 24, 2026. Its market cap has decreased by -22.64% in one year.
Market Cap
1.20B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.15
Market Cap Chart
Since November 10, 2021, BiOptic's market cap has decreased from 1.23B to 1.20B, a decrease of -2.91%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 1.20B | -9.17% |
| Dec 31, 2025 | 1.32B | 1.58% |
| Dec 31, 2024 | 1.30B | -2.59% |
| Dec 29, 2023 | 1.33B | 17.65% |
| Dec 30, 2022 | 1.13B | 7.14% |
| Dec 30, 2021 | 1.06B | -14.29% |
| Nov 10, 2021 | 1.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GenMont Biotech Incorporation | 1.54B |
| Enimmune | 1.40B |
| NeoCore Technology | 1.39B |
| Meribank Biotech | 1.36B |
| Abnova (Taiwan) | 1.35B |
| GeneReach Biotechnology | 1.19B |
| Holy Stone Healthcare | 1.16B |
| Taiwan Advance Bio-Pharmaceutical | 1.12B |